Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults

Free Radical Biology and Medicine

Volumn 45, Issue 3, 2008, Pages 242-255

  Liu, Fang ^a   Hindupur, Jagadish ^a   Nguyen, Jamie L ^a   Ruf, Katie J ^a   Zhu, Junyi ^a   Schieler, Jeremy L ^a   Bonham, Connie C ^b   Wood, Karl V ^b   Davisson, V Jo ^a   Rochet, Jean Christophe ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Aggresome; Dopamine; Glutathione; Heat shock protein; Methionine sulfoxide reductase; Neurodegeneration; Oxidative stress; Parkinson's disease; Proteasome; Protofibril; Rotenone; Synuclein

Indexed keywords

ACETYLCYSTEINE; ALPHA SYNUCLEIN; ALPHA TOCOPHEROL; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; METHIONINE SULFOXIDE REDUCTASE A; REACTIVE OXYGEN METABOLITE; ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RAT;

ACETYLCYSTEINE; ALPHA-SYNUCLEIN; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DOPAMINE; HUMANS; LEUPEPTINS; MESENCEPHALON; METHIONINE SULFOXIDE REDUCTASES; MICE; NEURONS; OXIDATION-REDUCTION; OXIDOREDUCTASES; PARKINSON DISEASE; RATS; ROTENONE; UNCOUPLING AGENTS; VITAMIN E;

EID: 46449097383     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.03.022     Document Type: Article

References (56)

1. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
2. Cookson M.R. The biochemistry of Parkinson's disease. Annu. Rev. Biochem. 74 (2005) 29-52
3. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
4. Orth M., and Schapira A.H. Mitochondrial involvement in Parkinson's disease. Neurochem. Int. 40 (2002) 533-541
5. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl. 3 (2003) S26-S38
6. McNaught K.S., and Olanow C.W. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. Ann. Neurol. 53 Suppl. 3 (2003) S73-S84 discussion S84-S86
7. Halliwell B. Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. N. Y. Acad. Sci. 962 (2002) 182-194
8. Farout L., and Friguet B. Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid. Redox Signal. 8 (2006) 205-216
9. Papa L., Gomes E., and Rockwell P. Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death. Apoptosis 12 (2007) 1389-1405
10. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14 (1978) 633-643
11. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. α-Synuclein in Lewy bodies. Nature 388 (1997) 839-840
12. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Williamson R.E., and Lansbury Jr. P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 97 (2000) 571-576
13. Li J., Uversky V.N., and Fink A.L. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein. Biochemistry 40 (2001) 11604-11613
14. Conway K.A., Rochet J.C., Bieganski R.M., and Lansbury Jr. P.T. Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct. Science 294 (2001) 1346-1349
15. Cole N.B., Murphy D.D., Lebowitz J., Di Noto L., Levine R.L., and Nussbaum R.L. Metal-catalyzed oxidation of α-synuclein: helping to define the relationship between oligomers, protofilaments and filaments. J. Biol. Chem. 280 (2005) 9678-9690
16. Rochet J.C. Novel therapeutic strategies for the treatment of protein-misfolding diseases. Expert Rev. Mol. Med. 9 (2007) 1-34
17. Tabner B.J., Turnbull S., El-Agnaf O.M., and Allsop D. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic. Biol. Med. 32 (2002) 1076-1083
18. Levine R.L., Moskovitz J., and Stadtman E.R. Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 50 (2000) 301-307
19. Moskovitz J., Jenkins N.A., Gilbert D.J., Copeland N.G., Jursky F., Weissbach H., and Brot N. Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc. Natl. Acad. Sci. USA 93 (1996) 3205-3208
20. Kantorow M., Hawse J.R., Cowell T.L., Benhamed S., Pizarro G.O., Reddy V.N., and Hejtmancik J.F. Methionine sulfoxide reductase A is important for lens cell viability and resistance to oxidative stress. Proc. Natl. Acad. Sci. USA 101 (2004) 9654-9659
21. Yermolaieva O., Xu R., Schinstock C., Brot N., Weissbach H., Heinemann S.H., and Hoshi T. Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation. Proc. Natl. Acad. Sci. USA 101 (2004) 1159-1164
22. Picot C.R., Petropoulos I., Perichon M., Moreau M., Nizard C., and Friguet B. Overexpression of MsrA protects WI-38 SV40 human fibroblasts against H2O2-mediated oxidative stress. Free Radic. Biol. Med. 39 (2005) 1332-1341
23. Sreekumar P.G., Kannan R., Yaung J., Spee C.K., Ryan S.J., and Hinton D.R. Protection from oxidative stress by methionine sulfoxide reductases in RPE cells. Biochem. Biophys. Res. Commun. 334 (2005) 245-253
24. Lowther W.T., Brot N., Weissbach H., Honek J.F., and Matthews B.W. Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase. Proc. Natl. Acad. Sci. USA 97 (2000) 6463-6468
25. Moskovitz J., Bar-Noy S., Williams W.M., Requena J., Berlett B.S., and Stadtman E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA 98 (2001) 12920-12925
26. Ruan H., Tang X.D., Chen M.L., Joiner M.L., Sun G., Brot N., Weissbach H., Heinemann S.H., Iverson L., Wu C.F., Hoshi T., and Joiner M.A. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc. Natl. Acad. Sci. USA 99 (2002) 2748-2753
27. Petropoulos I., Mary J., Perichon M., and Friguet B. Rat peptide methionine sulphoxide reductase: cloning of the cDNA, and down-regulation of gene expression and enzyme activity during aging. Biochem. J. 355 (2001) 819-825
28. Wassef R., Haenold R., Hansel A., Brot N., Heinemann S.H., and Hoshi T. Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms. J. Neurosci. 27 (2007) 12808-12816
29. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., Cao S., Caldwell K.A., Caldwell G.A., Marsischky G., Kolodner R.D., Labaer J., Rochet J.C., Bonini N.M., and Lindquist S. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006) 324-328
30. Outeiro T.F., Klucken J., Strathearn K.E., Liu F., Nguyen P., Rochet J.C., Hyman B.T., and McLean P.J. Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem. Biophys. Res. Commun. 351 (2006) 631-638
31. Outeiro T.F., Kontopoulos E., Altman S., Kufareva I., Strathearn K.E., Amore A.M., Volk C.B., Maxwell M.M., Rochet J.C., McLean P.J., Young A.B., Abagyan R., Feany M.B., Hyman B.T., and Kazantsev A. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317 (2007) 516-519
32. Kim H.Y., and Gladyshev V.N. Role of structural and functional elements of mouse methionine-S-sulfoxide reductase in its subcellular distribution. Biochemistry 44 (2005) 8059-8067
33. Liu F., Nguyen J.E., Hulleman J.D., Li L., and Rochet J.-C. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease. J. Neurochem. 105 (2008) 2435-2453
34. Crawford Jr. G.D., Le W.D., Smith R.G., Xie W.J., Stefani E., and Appel S.H. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12 (1992) 3392-3398
35. Conway K.A., Harper J.D., and Lansbury Jr. P.T. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39 (2000) 2552-2563
36. Rochet J.C., Conway K.A., and Lansbury Jr. P.T. Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry 39 (2000) 10619-10626
37. Uversky V.N., Yamin G., Souillac P.O., Goers J., Glaser C.B., and Fink A.L. Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett. 517 (2002) 239-244
38. Muqit M.M., Davidson S.M., Payne Smith M.D., MacCormac L.P., Kahns S., Jensen P.H., Wood N.W., and Latchman D.S. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Hum. Mol. Genet. 13 (2004) 117-135
39. Diaz-Corrales F.J., Asanuma M., Miyazaki I., Miyoshi K., and Ogawa N. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration. Neuroscience 133 (2005) 117-135
40. Johnston J.A., Ward C.L., and Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143 (1998) 1883-1898
41. Wigley W.C., Fabunmi R.P., Lee M.G., Marino C.R., Muallem S., DeMartino G.N., and Thomas P.J. Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol. 145 (1999) 481-490
42. Lee H.J., Shin S.Y., Choi C., Lee Y.H., and Lee S.J. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J. Biol. Chem. 277 (2002) 5411-5417
43. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., and Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23 (2003) 10756-10764
44. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res. Rev. 4 (2005) 288-314
45. Zhou W., Hurlbert M.S., Schaack J., Prasad K.N., and Freed C.R. Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866 (2000) 33-43
46. Petrucelli L., O'Farrell C., Lockhart P.J., Baptista M., Kehoe K., Vink L., Choi P., Wolozin B., Farrer M., Hardy J., and Cookson M.R. Parkin protects against the toxicity associated with mutant α-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36 (2002) 1007-1019
47. Zhou W., and Freed C.R. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem. 280 (2005) 43150-43158
48. Periquet M., Fulga T., Myllykangas L., Schlossmacher M.G., and Feany M.B. Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J. Neurosci. 27 (2007) 3338-3346
49. Sun H., Gao J., Ferrington D.A., Biesiada H., Williams T.D., and Squier T.C. Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase. Biochemistry 38 (1999) 105-112
50. Jung B., Lee E.H., Chung W.S., Lee S.J., Shin S.H., Joo S.H., Kim S.K., and Lee J.H. Increased viability of PC12 cells exposed to amyloid-beta peptide by transduction with human TAT-methionine sulfoxide reductase. Neuroreport 14 (2003) 2349-2353
51. Gabbita S.P., Aksenov M.Y., Lovell M.A., and Markesbery W.R. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73 (1999) 1660-1666
52. Rochet J.C., Outeiro T.F., Conway K.A., Ding T.T., Volles M.J., Lashuel H.A., Bieganski R.M., Lindquist S.L., and Lansbury P.T. Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. J. Mol. Neurosci. 23 (2004) 23-34
53. Glaser C.B., Yamin G., Uversky V.N., and Fink A.L. Methionine oxidation, alpha-synuclein and Parkinson's disease. Biochim. Biophys. Acta 1703 (2005) 157-169
54. Mirzaei H., Schieler J.L., Rochet J.-C., and Regnier F. Identification of rotenone-induced modifications in α-synuclein using affinity pull-down and tandem mass spectrometry. Anal. Chem. 78 (2006) 2422-2431
55. Tabner B.J., El-Agnaf O.M., Turnbull S., German M.J., Paleologou K.E., Hayashi Y., Cooper L.J., Fullwood N.J., and Allsop D. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J. Biol. Chem. 280 (2005) 35789-35792
56. Devi L., Raghavendran V., Prabhu B.M., Avadhani N.G., and Anandatheerthavarada H.K. Mitochondrial import and accumulation of alpha-synuclein impairs complex I in human dopaminergic neuronal cultures and Parkinson's disease brain. J. Biol. Chem. 283 (2008) 9089-9100